Home › Alopecia Areata › New York
Alopecia Areata clinical trials in New York
6 studies for Alopecia Areata are looking for participants at sites in New York.
Cities in New York
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Icahn School of Medicine at Mount Sinai, New York
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Oct 20, 2026 · NCT06873945A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Equity Medical /ID# 266680, New York
- Sadick Research Group LLC /ID# 266790, New York
RecruitingPhase 3
Ages 12 to 63 · All sexes · Updated Oct 19, 2026 · NCT06012240Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
- Icahn School of Medicine at Mount Sinai, New York
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Oct 16, 2026 · NCT07242638Dupilumab in the Treatment of Pediatric Alopecia Areata
- Icahn School of Medicine at Mount Sinai, New York
RecruitingPhase 2
Ages 6 to 17 · All sexes · Updated Sep 2, 2026 · NCT05866562Regeneron AA Multicenter (Dupilumab)
- Icahn School of Medicine at Mount Sinai, New York
- UR Dermatology at College Town, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT05551793Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Vitality Clinical Trials, Woodbury
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Jan 28, 2026 · NCT07133308From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.